Walgreens releases specialty pharmacy report

News
Article

Walgreens recently announced the release of its Specialty Pharmacy State of the Industry report. Keep reading to find out more.

Walgreens recently announced the release of its Specialty Pharmacy State of the Industry report, which offers a snapshot of the specialty pharmacy market's evolving trends, as well as solutions for managing costs and improving care.

The report is available online at

Recent Videos
Related Content
Q&A: Chain Pharmacist Shares Keys to Success in Retail Settings

Q&A: Chain Pharmacist Shares Keys to Success in Retail Settings

Lauren Massaro;James Rider, PharmD
November 21st 2024
Article

James Rider, PharmD, shared reflections on his experiences as a pharmacy manager at CVS.

Looking to the Future of Independent Pharmacy

Looking to the Future of Independent Pharmacy

Miranda Hester
July 13th 2022
Podcast

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

Q&A: Rite Aid Pharmacist Boosts Public Health Through Immunization and Clinical Programs

Q&A: Rite Aid Pharmacist Boosts Public Health Through Immunization and Clinical Programs

Lauren Massaro
November 18th 2024
Article

Drug Topics sat down with Adam J. James, PharmD, to discuss his journey from chain pharmacist to innovation leader at Rite Aid."

Podcast: Pharmacy Financing With First Financial Bank

Podcast: Pharmacy Financing With First Financial Bank

January 28th 2022
Podcast

Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.

FDA Roundup: Rosacea Treatment, Proposal to Remove Oral Phenylephrine from OTC Products

FDA Roundup: Rosacea Treatment, Proposal to Remove Oral Phenylephrine from OTC Products

Killian Meara
November 8th 2024
Article

Check out these important FDA updates from the week of November 4.

Lumateperone Demonstrates Efficacy in Reducing Symptomatic Relapse Risk in Schizophrenia

Lumateperone Demonstrates Efficacy in Reducing Symptomatic Relapse Risk in Schizophrenia

Lauren Biscaldi, MS, Managing Editor
November 5th 2024
Article

The drug is also approved to treat schizophrenia and bipolar depression.

© 2024 MJH Life Sciences

All rights reserved.